Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

Neurofibrillary tangles advance from layer II of the entorhinal cortex (EC-II) toward limbic and association cortices as Alzheimer's disease evolves. However, the mechanism involved in this hierarchical pattern of disease progression is unknown. We describe a transgenic mouse model in which overexpression of human tau P301L is restricted to EC-II. Tau pathology progresses from EC transgene-expressing neurons to neurons without detectable transgene expression, first to EC neighboring cells, followed by propagation to neurons downstream in the synaptic circuit such as the dentate gyrus, CA fields of the hippocampus, and cingulate cortex. Human tau protein spreads to these regions and coaggregates with endogenous mouse tau. With age, synaptic degeneration occurs in the entorhinal target zone and EC neurons are lost. These data suggest that a sequence of progressive misfolding of tau proteins, circuit-based transfer to new cell populations, and deafferentation induced degeneration are part of a process of tau-induced neurodegeneration.

[1]  A. Hjorth-Simonsen,et al.  Origin and termination of the hippocampal perforant path in the rat studied by silver impregnation , 1972, The Journal of comparative neurology.

[2]  F. Wouters,et al.  Removal of Pattern-breaking Sequences in Microtubule Binding Repeats Produces Instantaneous Tau Aggregation and Toxicity* , 2006, Journal of Biological Chemistry.

[3]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[4]  N. Otsuka,et al.  Paired helical filaments in astrocytes: electron microscopy and immunohistochemistry in a case of atypical Alzheimer's disease , 2004, Acta Neuropathologica.

[5]  M. Witter The perforant path: projections from the entorhinal cortex to the dentate gyrus. , 2007, Progress in brain research.

[6]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[7]  A. R. Damasio,et al.  Memory‐related neural systems in Alzheimer's disease , 1990, Neurology.

[8]  B. Hyman,et al.  A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50 , 1988, Brain Research.

[9]  J. Kimura,et al.  Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. , 1995, The American journal of pathology.

[10]  Julie A. Harris,et al.  Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.

[11]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[12]  Masahiro Yasuda,et al.  CaMKII Activation in the Entorhinal Cortex Disrupts Previously Encoded Spatial Memory , 2006, Neuron.

[13]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[14]  P. Davies,et al.  Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. , 2010, Journal of Alzheimer's disease : JAD.

[15]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Y. Barde,et al.  Neurotrophins are required for nerve growth during development , 2001, Nature Neuroscience.

[17]  M. Ahlijanian,et al.  Tau transgenic mice as models for cerebrospinal fluid tau biomarkers. , 2011, Journal of Alzheimer's disease : JAD.

[18]  Stephen J. Smith,et al.  Array Tomography: A New Tool for Imaging the Molecular Architecture and Ultrastructure of Neural Circuits , 2007, Neuron.

[19]  T. van Groen,et al.  Entorhinal cortex of the mouse: Cytoarchitectonical organization , 2001, Hippocampus.

[20]  Y. Geinisman Loss of axosomatic synapses in the dentate gyrus of aged rats , 1979, Brain Research.

[21]  Papasozomenos Sc Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. , 1989 .

[22]  B T Hyman,et al.  Stereology: A Practical Primer for Neuropathology , 1998, Journal of neuropathology and experimental neurology.

[23]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[24]  T. Jessell,et al.  Regulation of Motor Neuron Pool Sorting by Differential Expression of Type II Cadherins , 2002, Cell.

[25]  S. Papasozomenos Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[26]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[27]  Douglas Galasko,et al.  The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments , 1997, Journal of neurochemistry.

[28]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[29]  S. Papasozomenos Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[30]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[31]  Menno P. Witter,et al.  Entorhinal projections to the hippocampal CA1 region in the rat: An underestimated pathway , 1988, Neuroscience Letters.

[32]  A. Sun,et al.  Comparative Analysis of an Improved Thioflavin-S Stain, Gallyas Silver Stain, and Immunohistochemistry for Neurofibrillary Tangle Demonstration on the Same Sections , 2002, Journal of Histochemistry and Cytochemistry.

[33]  T. van Groen Entorhinal cortex of the mouse: Cytoarchitectonical organization , 2001, Hippocampus.

[34]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[35]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[36]  F. Gallyas,et al.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development. , 1971, Acta morphologica Academiae Scientiarum Hungaricae.

[37]  B. Hyman,et al.  Caspase activation precedes and leads to tangles , 2010, Nature.

[38]  M. Diamond,et al.  Propagation of Tau Misfolding from the Outside to the Inside of a Cell* , 2009, Journal of Biological Chemistry.

[39]  Deepak N. Pandya,et al.  Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents , 1975, Brain Research.

[40]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[41]  B. Teter,et al.  Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease , 2006, Nature Neuroscience.

[42]  G. V. Van Hoesen,et al.  Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.

[43]  O. Steward,et al.  Topographic organization of the projections from the entorhinal area to the hippocampal formation of the rat , 1976, The Journal of comparative neurology.

[44]  Papasozomenos Sc Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989 .

[45]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[46]  J. Goldman,et al.  Glial Inclusions in CNS Degenerative Diseases , 1996, Journal of neuropathology and experimental neurology.

[47]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[48]  M. Witter,et al.  What Does the Anatomical Organization of the Entorhinal Cortex Tell Us? , 2008, Neural plasticity.

[49]  N. Schaeren-Wiemers,et al.  A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes , 1993, Histochemistry.

[50]  S. Scheff,et al.  Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. , 2006, Journal of Alzheimer's disease : JAD.

[51]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[52]  Y. Geinisman,et al.  Partial deafferentation of neurons in the dentate gyrus of the senescent rat , 1977, Brain Research.

[53]  H. Akiyama,et al.  TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. , 2007, Brain : a journal of neurology.

[54]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[55]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.